We are live on ! Find out more
Acadian Asset Management

Acadian Asset Management Portfolio holdings

AUM $70.5B
1-Year Est. Return 36%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$22.8B
AUM Growth
+$2.51B
Cap. Flow
+$1.41B
Cap. Flow %
6.19%
Top 10 Hldgs %
17.92%
Holding
2,069
New
288
Increased
592
Reduced
638
Closed
325

Top Buys

Rank Stock Value
1
BP icon
BP
BP
+$342M
2
RIO icon
Rio Tinto
RIO
+$154M
3
VIPS icon
Vipshop
VIPS
+$139M
4
DB icon
Deutsche Bank
DB
+$118M
5
CSCO icon
Cisco
CSCO
+$115M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$133M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$104M
3
PEP icon
PepsiCo
PEP
+$92.4M
4
COST icon
Costco
COST
+$90.7M
5
CI icon
Cigna
CI
+$84M

Sector Composition

Rank Sector Weight
1 Technology 26.43%
2 Healthcare 15.31%
3 Consumer Staples 11.96%
4 Industrials 9.21%
5 Materials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNF
1701
CNFinance Holdings
CNF
$37.9M
$3K ﹤0.01%
143
+139
+3,475% +$2.82K
LPCN icon
1702
Lipocine
LPCN
$17.2M
$3K ﹤0.01%
706
-4,298
-86% -$33.2K
FRGI
1703
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$3K ﹤0.01%
406
-6,557
-94% -$54.4K
CDAK
1704
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$3K ﹤0.01%
23,915
STAB
1705
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$3K ﹤0.01%
211,836
-223,026
-51% -$20.6K
ALLR
1706
Allarity Therapeutics
ALLR
$22.8M
0
ARCT icon
1707
Arcturus Therapeutics
ARCT
$214M
$2K ﹤0.01%
+100
New +$1.79K
BSBK icon
1708
Bogota Financial
BSBK
$111M
$2K ﹤0.01%
+209
New +$2.34K
RUBY
1709
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
179,676
-1,097,520
-86% -$229K
AR icon
1710
Antero Resources
AR
$11.6B
$1K ﹤0.01%
49
-96,325
-100% -$2.54M
CEG icon
1711
Constellation Energy
CEG
$98.6B
$1K ﹤0.01%
21
-48,712
-100% -$3.94M
FLNG icon
1712
FLEX LNG
FLNG
$1.58B
$1K ﹤0.01%
50
XP icon
1713
XP
XP
$8.01B
$1K ﹤0.01%
+99
New +$1.41K
ABOS icon
1714
Acumen Pharmaceuticals
ABOS
$178M
-15,741
Closed -$85K
ADCT icon
1715
ADC Therapeutics
ADCT
$150M
-2,695
Closed -$10K
ADVM
1716
DELISTED
Adverum Biotechnologies
ADVM
-12,921
Closed -$74K
AEP icon
1717
American Electric Power
AEP
$67.3B
$0 ﹤0.01%
6
-11,721
-100% -$1.07M
AFG icon
1718
American Financial Group
AFG
$12B
-48,695
Closed -$6.68M
AFRM icon
1719
Affirm
AFRM
$25.7B
-5,356
Closed -$51K
ALHC icon
1720
Alignment Healthcare
ALHC
$2.74B
-50,750
Closed -$595K
ALKS icon
1721
Alkermes
ALKS
$8.26B
-143,106
Closed -$3.73M
ALNY icon
1722
Alnylam Pharmaceuticals
ALNY
$29.6B
-917
Closed -$217K
ALT icon
1723
Altimmune
ALT
$583M
$0 ﹤0.01%
1
ALTO icon
1724
Alto Ingredients
ALTO
$323M
-152,677
Closed -$439K
AMAL icon
1725
Amalgamated Financial
AMAL
$1.5B
-37,067
Closed -$853K

Similar funds

Acadian Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Acadian Asset Management held 2,069 positions worth $22.8B, up 12% from $20.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Acadian Asset Management deployed $1.41B of net new capital in Q1 2023, opening 288 new positions and adding to 592 existing holdings. Its largest new stake was Deutsche Bank: 9,902,417 shares worth $101M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was MetLife, an estimated $133M trimmed.

  • Acadian Asset Management's largest Q1 2023 buy was Deutsche Bank: 9,902,417 shares worth $101M.
  • Acadian Asset Management added most to BP in Q1 2023, an estimated $342M increase.
  • Acadian Asset Management's biggest Q1 2023 reduction was MetLife, cutting an estimated $133M.
  • Acadian Asset Management fully exited Sociedad Química y Minera de Chile in Q1 2023, selling an estimated $24.4M.
  • Acadian Asset Management's ten largest holdings make up 18% of its $22.8B portfolio in Q1 2023.
  • Acadian Asset Management opened 288 new positions and closed 325 in Q1 2023.
  • Acadian Asset Management's portfolio value rose 12% quarter-over-quarter to $22.8B.

Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.